HIFI

Berry Oncology launches HIFI Pan-Cancer Screening, a multi-cancer early screening product for detecting six high-risk cancers at one time

Retrieved on: 
Thursday, June 23, 2022

HIFI Pan-Cancer Screening is the first early screening product for multiple cancer types using whole genome sequencing (WGS) of cell-free DNA (cfDNA) worldwide.

Key Points: 
  • HIFI Pan-Cancer Screening is the first early screening product for multiple cancer types using whole genome sequencing (WGS) of cell-free DNA (cfDNA) worldwide.
  • The self-iterative HIFI technology platform can reduce the costs of product development and testing services, and thus making early screening for multiple cancers more affordable.
  • The launch of the multi-cancer early screening product will further reinforce Berry Oncology's leadership in the early screening sector."
  • Moving forward, Berry Oncology will continue to optimize its technology system and iterate early screening products to deliver more advanced early cancer screening solutions in accordance with the actual market demand and environment.

Berry Oncology Launches an Innovative Self-Iterative "HIFI" System

Retrieved on: 
Thursday, May 19, 2022

BEIJING, May 18, 2022 /PRNewswire/ --Berry Oncology, a leadingcompany in the global industryfor genetic testing and early screening of tumors, recently launched a HIFI system.

Key Points: 
  • BEIJING, May 18, 2022 /PRNewswire/ --Berry Oncology, a leadingcompany in the global industryfor genetic testing and early screening of tumors, recently launched a HIFI system.
  • The advantage of the HIFI system is that it can maintain the iterativeness and scalability of the core model through iterative optimization of biomarkers.
  • Starting from the first liver cancer early screening product "Liver Screening" launched in August 2020, Berry Oncology has built early cancer screening models from multi-omicsand multi-dimensional data, which leads to the emergence of the HIFI system.
  • Berry Oncology is a leading company in the global industry for oncology genomic testing and early cancer screening.

Refurbishment specialist RECOMMERCE strengthens its capital through affiliation with major French industrial groups

Retrieved on: 
Monday, February 7, 2022

PARIS, Feb. 7, 2022 /PRNewswire/ --A pioneer in refurbishment since 2009, Recommerce has decided to join forces with major retailand industrial leaders.

Key Points: 
  • PARIS, Feb. 7, 2022 /PRNewswire/ --A pioneer in refurbishment since 2009, Recommerce has decided to join forces with major retailand industrial leaders.
  • Recommerce buys used equipment from private individuals and professionals, refurbishing and reselling it with a warranty.
  • The CircularX platform aims to offer all solutions (pricing, software, traceability, routing, logistics...) to support the buy-back, refurbishment and resale of all types of products.
  • Please note that the Recommerce and CircularX brands and logos are registered and belong to the RECOMMERCE SOLUTIONS company.

Refurbishment specialist RECOMMERCE strengthens its capital through affiliation with major French industrial groups

Retrieved on: 
Monday, February 7, 2022

PARIS, Feb. 7, 2022 /PRNewswire/ --A pioneer in refurbishment since 2009, Recommerce has decided to join forces with major retailand industrial leaders.

Key Points: 
  • PARIS, Feb. 7, 2022 /PRNewswire/ --A pioneer in refurbishment since 2009, Recommerce has decided to join forces with major retailand industrial leaders.
  • Recommerce buys used equipment from private individuals and professionals, refurbishing and reselling it with a warranty.
  • The CircularX platform aims to offer all solutions (pricing, software, traceability, routing, logistics...) to support the buy-back, refurbishment and resale of all types of products.
  • Please note that the Recommerce and CircularX brands and logos are registered and belong to the RECOMMERCE SOLUTIONS company.

HUXTON announces plans to bring weed to the Metaverse

Retrieved on: 
Wednesday, January 12, 2022

SCOTTSDALE, Ariz., Jan. 12, 2022 /PRNewswire/ --HUXTON, a leading lifestyle cannabis brand, is exploring opportunities to bring its weed to the metaverse.

Key Points: 
  • SCOTTSDALE, Ariz., Jan. 12, 2022 /PRNewswire/ --HUXTON, a leading lifestyle cannabis brand, is exploring opportunities to bring its weed to the metaverse.
  • "Adults want to interact in virtual environments with brands and objects that they identify with in the real world.
  • Providing them with the ability to get 'digitally stoned' is a unique opportunity that we are actively exploring" says Dustin Johnson, Co-Founder of HUXTON.
  • HUXTON is best known for their simplified cannabis offerings available in three unique blends.

HUXTON announces expansion into Oregon with Urban Pharms

Retrieved on: 
Tuesday, January 11, 2022

SCOTTSDALE, Ariz., Jan. 11, 2022 /PRNewswire/ -- HUXTON , Arizona-based lifestyle cannabis brand, today announces the expansion of their footprint in the Pacific Northwest.

Key Points: 
  • SCOTTSDALE, Ariz., Jan. 11, 2022 /PRNewswire/ -- HUXTON , Arizona-based lifestyle cannabis brand, today announces the expansion of their footprint in the Pacific Northwest.
  • HUXTON products will be available for purchase in select retailers throughout Oregon starting in January 2022.
  • HUXTON's offerings have been brought to Oregon in partnership with Urban Pharms.
  • Urban Pharms, one of the leading wholesalers in the Oregon market, is licensed to manufacture, distribute and sell HUXTON's line of cannabis products throughout the state.

Berry Oncology Releases Latest Research Results on Early Screening for Multiple Cancers

Retrieved on: 
Wednesday, October 13, 2021

SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Berry Oncology, a Chinese oncology genomic testing company, was invited to the inaugural International Biopharma Industry Week in Shanghai (IBIWS) running from October 11-14, where CEOJun Zhoudelivered a much-anticipated keynote speech at the "2021 Future Healthcare Industry Summit" subforum, unveiling the company's latest research results on early screening for multiple cancers.

Key Points: 
  • SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Berry Oncology, a Chinese oncology genomic testing company, was invited to the inaugural International Biopharma Industry Week in Shanghai (IBIWS) running from October 11-14, where CEOJun Zhoudelivered a much-anticipated keynote speech at the "2021 Future Healthcare Industry Summit" subforum, unveiling the company's latest research results on early screening for multiple cancers.
  • Jun Zhou said, "In this multi-cancer early screening study, Berry Oncology specifically chose lung and gastrointestinal cancers as the breakthrough point as they pose the highest threat in terms of morbidity and mortality in China.
  • From the outset of our product design, we specifically took into account the tumorigenic characteristics of the Chinese population and which cancer most urgently needs early screening solutions."
  • As one of the earliest Chinese companies engaged in the early screening of cancers, Berry Oncology is the first to apply its self-developed HIFI method to the early screening of liver and lung cancers.